Cite
APA Citation
Yang, J. C., Sequist, L. V., Geater, S. L., Tsai, C., Mok, T. S. K., Schuler, M., Yamamoto, N., Yu, C., Ou, S. I., Zhou, C., Massey, D., Zazulina, V., & Wu, Y. (n.d.). clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6. Lancet oncology, 16(7), 830–838. http://access.bl.uk/ark:/81055/vdc_100025942553.0x000015